Stock Events

Stock Events

Search...

Alnylam Pharmaceuticals (ALNY) Q3 2017 Earnings

9AugConfirmed

Q4 2016

Q1 2017

Q2 2017

Q3 2017

-1.37

-1.29

-1.21

-1.13

Details

Expected EPS

-1.16

Actual EPS

-1.34

Surprise EPS

-0.18

Surprise Percent

+15.52%

Description

Alnylam Pharmaceuticals (ALNY) has reported earnings of -1.34 per share for Q3 2017.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.